Pharma Reviews: INTERVIEW: Cadila Health MD pins growth on diabetes, anaemia drugs

Patel believes the company can see double-digit annual growth in earnings till 2023 with its focus on the Indian and the US drug markets.
Read more: INTERVIEW: Cadila Health MD pins growth on diabetes, anaemia drugs